These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16539921)

  • 1. [Sickle cell disease: registry of the Spanish Society of Pediatric Hematology].
    García Arias MB; Cantalejo López MA; Cela de Julián ME; Bravo Clouzet R; Galarón García P; Beléndez Bieler C
    An Pediatr (Barc); 2006 Jan; 64(1):78-84. PubMed ID: 16539921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of the Spanish registry of haemoglobinopathies in children and adults.
    Bardón Cancho EJ; García-Morín M; Beléndez C; Velasco P; Benéitez D; Ruiz-Llobet A; Berrueco R; Argilés B; Cervera Á; Salinas JA; Vecilla C; Gondra A; Vallés G; Murciano T; Bermúdez M; Cela E;
    Med Clin (Barc); 2020 Aug; 155(3):95-103. PubMed ID: 32113697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sickle cell disease diagnosis over a decade in a pediatric hematology unit].
    Greppi Q C; Fuentes G MP; Sotomayor F C; Verdugo L P
    Andes Pediatr; 2022 Aug; 93(4):504-510. PubMed ID: 37906848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National registry of hemoglobinopathies in Spain (REPHem).
    Cela E; Bellón JM; de la Cruz M; Beléndez C; Berrueco R; Ruiz A; Elorza I; Díaz de Heredia C; Cervera A; Vallés G; Salinas JA; Coll MT; Bermúdez M; Prudencio M; Argilés B; Vecilla C;
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27804209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell disease in Germany: Results from a national registry.
    Kunz JB; Lobitz S; Grosse R; Oevermann L; Hakimeh D; Jarisch A; Cario H; Beier R; Schenk D; Schneider D; Groß-Wieltsch U; Prokop A; Heine S; Khurana C; Erlacher M; Dürken M; Linke C; Frühwald M; Corbacioglu S; Claviez A; Metzler M; Ebinger M; Full H; Wiesel T; Eberl W; Reinhard H; Tagliaferri L; Allard P; Karapanagiotou-Schenkel I; Rother LM; Beck D; Le Cornet L; Kulozik AE;
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28130. PubMed ID: 31867835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization of children with sickle cell disease in a region with increasing immigration rates.
    Colombatti R; Dalla Pozza LV; Mazzucato M; Sainati L; Pierobon M; Facchin P
    Haematologica; 2008 Mar; 93(3):463-4. PubMed ID: 18310539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
    Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
    Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.
    Colombatti R; Palazzi G; Masera N; Notarangelo LD; Bonetti E; Samperi P; Barone A; Perrotta S; Facchini E; Miano M; Del Vecchio GC; Guerzoni ME; Corti P; Menzato F; Cesaro S; Casale M; Rigano P; Forni GL; Russo G; Sainati L;
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28868627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.
    Lê PQ; Gulbis B; Dedeken L; Dupont S; Vanderfaeillie A; Heijmans C; Huybrechts S; Devalck C; Efira A; Dresse MF; Rozen L; Benghiat FS; Ferster A
    Pediatr Blood Cancer; 2015 Nov; 62(11):1956-61. PubMed ID: 26173735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of sickle cell disease in Germany following recent large-scale immigration.
    Kunz JB; Cario H; Grosse R; Jarisch A; Lobitz S; Kulozik AE
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28383793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changing Epidemiology of Pediatric Hemoglobinopathy Patients in Northern Alberta, Canada.
    Corriveau-Bourque C; Bruce AA
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):595-9. PubMed ID: 26422283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective cholecystectomy reduces morbidity of cholelithiasis in pediatric sickle cell disease.
    Goodwin EF; Partain PI; Lebensburger JD; Fineberg NS; Howard TH
    Pediatr Blood Cancer; 2017 Jan; 64(1):113-120. PubMed ID: 27643455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy.
    Jordan L; Adams-Graves P; Kanter-Washko J; Oneal PA; Sasane M; Vekeman F; Bieri C; Magestro M; Marcellari A; Duh MS
    Curr Med Res Opin; 2015 Mar; 31(3):513-23. PubMed ID: 25495135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
    Bello-Manga H; DeBaun MR; Kassim AA
    Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.